TrialBMC cancer2015

Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum.

R Glynne-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.